{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T04:45:16Z","timestamp":1774413916771,"version":"3.50.1"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,10,30]],"date-time":"2018-10-30T00:00:00Z","timestamp":1540857600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1007\/s00417-018-4167-6","type":"journal-article","created":{"date-parts":[[2018,10,29]],"date-time":"2018-10-29T22:56:12Z","timestamp":1540853772000},"page":"41-48","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Hyperreflective foci in Stargardt disease: 1-year follow-up"],"prefix":"10.1007","volume":"257","author":[{"given":"Maurizio","family":"Battaglia Parodi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2891-2012","authenticated-orcid":false,"given":"Riccardo","family":"Sacconi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Romano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Bandello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,10,30]]},"reference":[{"key":"4167_CR1","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1016\/j.ophtha.2008.12.039","volume":"116","author":"M Bolz","year":"2009","unstructured":"Bolz M, Schmidt-Erfurth U, Deak G, Diabetic Retinopathy Research Group Vienna et al (2009) Optical coherence tomographic hyper-reflective foci: a morphological sign of lipid extravasation in diabetic macular edema. Ophthalmology 116:914\u2013920","journal-title":"Ophthalmology"},{"key":"4167_CR2","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1097\/IAE.0b013e318217ffc7","volume":"32","author":"K Ogino","year":"2012","unstructured":"Ogino K, Murakami T, Tsujikawa A et al (2012) Characteristics of optical coherence tomographic hyperreflective foci in retinal vein occlusion. Retina 32:77\u201385","journal-title":"Retina"},{"key":"4167_CR3","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1016\/j.ophtha.2012.10.018","volume":"120","author":"JG Christenbury","year":"2013","unstructured":"Christenbury JG, Folgar FF, O\u2019Connell R et al (2013) Progression of intermediate age-related macular degeneration with proliferation and inner retinal migration of hyperreflective foci. Ophthalmology 120:1038\u20131045","journal-title":"Ophthalmology"},{"key":"4167_CR4","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1159\/000342159","volume":"229","author":"G Coscas","year":"2013","unstructured":"Coscas G, De Benedetto U, Coscas F et al (2013) Hyperreflective dots: a new spectral-domain optical coherence tomography entity for follow-up and prognosis in exudative age-related macular degeneration. Ophthalmologica 229:32\u201337","journal-title":"Ophthalmologica"},{"key":"4167_CR5","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1097\/IAE.0000000000000336","volume":"35","author":"U Benedetto De","year":"2015","unstructured":"De Benedetto U, Sacconi R, Pierro L, Lattanzio R, Bandello F (2015) Optical coherence tomographic hyperreflective foci in early stages of diabetic retinopathy. Retina 35:449\u2013453","journal-title":"Retina"},{"key":"4167_CR6","doi-asserted-by":"publisher","first-page":"435","DOI":"10.2147\/OPTH.S58164","volume":"8","author":"M Kuroda","year":"2014","unstructured":"Kuroda M, Hirami Y, Hata M, Mandai M, Takahashi M, Kurimoto Y (2014) Intraretinal hyperreflective foci on spectral-domain optical coherence tomography images of patients with retinitis pigmentosa. Clin Ophthalmol 8:435\u2013440","journal-title":"Clin Ophthalmol"},{"key":"4167_CR7","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1001\/jamaophthalmol.2014.5604","volume":"133","author":"N Piri","year":"2015","unstructured":"Piri N, Nesmith BLW, Schaal S (2015) Choroidal hyperreflective foci in Stargardt disease shown by spectral-domain optical coherence tomography imaging. Correlation with disease severity. JAMA Ophthalmol 133:398\u2013405","journal-title":"JAMA Ophthalmol"},{"key":"4167_CR8","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.ajo.2016.02.002","volume":"164","author":"KC Chen","year":"2016","unstructured":"Chen KC, Jung JJ, Curcio CA et al (2016) Intraretinal hyperreflective foci in acquired vitelliform lesions of the macula: clinical and histologic study. Am J Ophthalmol 164:89\u201398","journal-title":"Am J Ophthalmol"},{"key":"4167_CR9","doi-asserted-by":"publisher","first-page":"201","DOI":"10.5301\/ejo.5000878","volume":"27","author":"M Battaglia Parodi","year":"2017","unstructured":"Battaglia Parodi M, Iacono P, Romano F, Bolognesi G, Fasce F, Bandello F (2017) Optical coherence tomography in Best vitelliform macular dystrophy. Eur J Ophthalmol 27:201\u2013204","journal-title":"Eur J Ophthalmol"},{"key":"4167_CR10","doi-asserted-by":"publisher","unstructured":"Battaglia Parodi M, Iacono P, Romano F, Bandello F (2017) Spectral domain optical coherence tomography features in different stages of best vitelliform macular dystrophy. Retina. \n                    https:\/\/doi.org\/10.1097\/IAE.0000000000001634","DOI":"10.1097\/IAE.0000000000001634"},{"key":"4167_CR11","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1001\/archopht.117.4.504","volume":"117","author":"GA Fishman","year":"1999","unstructured":"Fishman GA, Stone EM, Grover S, Derlacki DJ, Haines HL, Hockey RR (1999) Variation of clinical expression in patients with Stargardt dystrophy and sequence variations in the ABCR gene. Arch Ophthalmol 117:504\u2013510","journal-title":"Arch Ophthalmol"},{"key":"4167_CR12","first-page":"391","volume":"36","author":"S Grisanti","year":"1995","unstructured":"Grisanti S, Guidry C (1995) Transdifferentiation of retinal pigment epithelial cells from epithelial to mesenchymal phenotype. Invest Ophthalmol Vis Sci 36:391\u2013405","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"4167_CR13","doi-asserted-by":"publisher","first-page":"3147","DOI":"10.1101\/gad.1700108","volume":"22","author":"JW Kim","year":"2008","unstructured":"Kim JW, Kang KH, Burrola P, Mak TW, Lemke G (2008) Retinal degeneration triggered by inactivation of PTEN in the retinal pigment epithelium. Genes Dev 22:3147\u20133157","journal-title":"Genes Dev"},{"key":"4167_CR14","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1002\/emmm.201302692","volume":"5","author":"F Sennlaub","year":"2013","unstructured":"Sennlaub F, Auvynet C, Calippe B et al (2013) CCR2(+) monocytes infiltrate atrophic lesions in age-related macular disease and mediate photoreceptor degeneration in experimental subretinal inflammation in Cx3cr1 deficient mice. EMBO Mol Med 5:1775\u20131793","journal-title":"EMBO Mol Med"},{"key":"4167_CR15","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1007\/s00417-015-3094-z","volume":"253","author":"EM Lad","year":"2015","unstructured":"Lad EM, Cousins SW, Van Arnam JS, Proia AD (2015) Abundance of infiltrating CD163+ cells in the retina of postmortem eyes with dry and neovascular age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol 253:1941\u20131945","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"4167_CR16","doi-asserted-by":"publisher","first-page":"9228","DOI":"10.1523\/JNEUROSCI.22-21-09228.2002","volume":"22","author":"T Harada","year":"2002","unstructured":"Harada T, Harada C, Kohsaka S et al (2002) Microglia-Muller glia cell interactions control neurotrophic factor production during light-induced retinal degeneration. J Neurosci 22:9228\u20139236","journal-title":"J Neurosci"},{"key":"4167_CR17","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1007\/978-1-4614-3209-8_47","volume":"801","author":"AI Arroba","year":"2014","unstructured":"Arroba AI, Alvarez-Lindo N, van Rooijen N, de la Rosa EJ (2014) Microglia-M\u00fcller glia crosstalk in the rd10 mouse model of retinitis pigmentosa. Adv Exp Med Biol 801:373\u2013379","journal-title":"Adv Exp Med Biol"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00417-018-4167-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-018-4167-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-018-4167-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,30]],"date-time":"2019-10-30T17:13:06Z","timestamp":1572455586000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00417-018-4167-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,30]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["4167"],"URL":"https:\/\/doi.org\/10.1007\/s00417-018-4167-6","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,30]]},"assertion":[{"value":"15 April 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"All authors have no affiliations with or involvement in any organization or entity with any financial interest in the subject matter or materials discussed in this manuscript.Maurizio Battaglia Parodi, Riccardo Sacconi and Francesco Romano: none.Francesco Bandello is a consultant for Alcon (Fort Worth,Texas,USA), Alimera Sciences (Alpharetta, Georgia, USA), Allergan Inc. (Irvine, California,USA), Farmila-Thea (Clermont-Ferrand, France), Bayer Shering-Pharma (Berlin, Germany), Bausch and Lomb (Rochester, New York, USA), Genentech (San Francisco, California, USA), Hoffmann-La-Roche (Basel, Switzerland), NovagaliPharma (\u00c9vry, France), Novartis (Basel, Switzerland), Sanofi-Aventis (Paris, France), Thrombogenics (Heverlee,Belgium), and Zeiss (Dublin, USA).The authors have no proprietary interest in the materials used in this study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}